Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Fox

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
BMJ (Clinical Research Ed.)|May 2, 2012
Late onset type 1 diabetesDaniel Lasserson, Robin Fox, Andrew Farmer
Practical Neurology|January 25, 2015
An unusual cause of seizuresRobin Fox, Rosie Heartshorne, Christopher Kobylecki, et al.
BMJ Open|February 14, 2020
Tackling statin intolerance with n-of-1 trials (TaSINI) in primary care: protocol for a feasibility randomised trial to increase statin adherenceKate Tudor, Jenny Brooks, Jeremy Howick, et al.
Circulation. Cardiovascular Quality and Outcomes|June 14, 2022
Unblinded and Blinded N-of-1 Trials Versus Usual Care: A Randomized Controlled Trial to Increase Statin Uptake in Primary CareKate Tudor, Jenny Brooks, Jeremy Howick, et al.
BMJ Open|October 20, 2020
Risks of use and non-use of antibiotics in primary care: qualitative study of prescribers' viewsOlga Boiko, Caroline Burgess, Robin Fox, et al.
The New Zealand Medical Journal|March 26, 2026
Iatrogenic cerebral amyloid angiopathy secondary to cadaveric lyophilised dural graft in childhood: a case in New ZealandChuen Siang Low, Sarah Buchanan, Nicholas Cutfield, et al.
Journal of the Peripheral Nervous System : JPNS|June 10, 2016
A novel DNMT1 mutation associated with early onset hereditary sensory and autonomic neuropathy, cataplexy, cerebellar atrophy, scleroderma, endocrinopathy, and common variable immune deficiencyRobin Fox, John Ealing, Helen Murphy, et al.
Lancet (London, England)|October 7, 2023
Life at The Lancet: a collection of memoriesDorothy Bonn, David Sharp, Robin Fox, et al.
BMC Medicine|July 17, 2018
Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research DatalinkJohn Wilding, Thomas Godec, Kamlesh Khunti, et al.
Diabetes, Obesity & Metabolism|November 12, 2019
A food-based, low-energy, low-carbohydrate diet for people with type 2 diabetes in primary care: A randomized controlled feasibility trialElizabeth Morris, Paul Aveyard, Pamela Dyson, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
BMJ (Clinical Research Ed.)|May 2, 2012
Late onset type 1 diabetesDaniel Lasserson, Robin Fox, Andrew Farmer
Practical Neurology|January 25, 2015
An unusual cause of seizuresRobin Fox, Rosie Heartshorne, Christopher Kobylecki, et al.
BMJ Open|February 14, 2020
Tackling statin intolerance with n-of-1 trials (TaSINI) in primary care: protocol for a feasibility randomised trial to increase statin adherenceKate Tudor, Jenny Brooks, Jeremy Howick, et al.
Circulation. Cardiovascular Quality and Outcomes|June 14, 2022
Unblinded and Blinded N-of-1 Trials Versus Usual Care: A Randomized Controlled Trial to Increase Statin Uptake in Primary CareKate Tudor, Jenny Brooks, Jeremy Howick, et al.
BMJ Open|October 20, 2020
Risks of use and non-use of antibiotics in primary care: qualitative study of prescribers' viewsOlga Boiko, Caroline Burgess, Robin Fox, et al.
The New Zealand Medical Journal|March 26, 2026
Iatrogenic cerebral amyloid angiopathy secondary to cadaveric lyophilised dural graft in childhood: a case in New ZealandChuen Siang Low, Sarah Buchanan, Nicholas Cutfield, et al.
Journal of the Peripheral Nervous System : JPNS|June 10, 2016
A novel DNMT1 mutation associated with early onset hereditary sensory and autonomic neuropathy, cataplexy, cerebellar atrophy, scleroderma, endocrinopathy, and common variable immune deficiencyRobin Fox, John Ealing, Helen Murphy, et al.
Lancet (London, England)|October 7, 2023
Life at The Lancet: a collection of memoriesDorothy Bonn, David Sharp, Robin Fox, et al.
BMC Medicine|July 17, 2018
Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research DatalinkJohn Wilding, Thomas Godec, Kamlesh Khunti, et al.
Diabetes, Obesity & Metabolism|November 12, 2019
A food-based, low-energy, low-carbohydrate diet for people with type 2 diabetes in primary care: A randomized controlled feasibility trialElizabeth Morris, Paul Aveyard, Pamela Dyson, et al.
Pageof 5